Vincerx Pharma, Inc. (VINC)
VINC Stock Price Chart
Explore Vincerx Pharma, Inc. interactive price chart. Choose custom timeframes to analyze VINC price movements and trends.
VINC Company Profile
Discover essential business fundamentals and corporate details for Vincerx Pharma, Inc. (VINC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
27 May 2020
Employees
12.00
Website
https://vincerx.comCEO
Raquel E. Izumi
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.
VINC Financial Timeline
Browse a chronological timeline of Vincerx Pharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Earnings released on 4 Sept 2025
Earnings released on 28 Aug 2025
Earnings released on 15 May 2025
EPS came in at -$0.91 .
Earnings released on 27 Mar 2025
EPS came in at -$4.20 falling short of the estimated -$3.40 by -23.53%.
Stock split effective on 28 Jan 2025
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Nov 2024
EPS came in at -$3.40 matching the estimated -$3.40.
Earnings released on 8 Aug 2024
EPS came in at -$1.00 surpassing the estimated -$3.40 by +70.59%.
Earnings released on 14 May 2024
EPS came in at -$6.80 falling short of the estimated -$5.20 by -30.77%.
Earnings released on 29 Mar 2024
EPS came in at -$4.60 surpassing the estimated -$8.40 by +45.24%, while revenue for the quarter reached $1.31M .
Earnings released on 14 Nov 2023
EPS came in at -$9.20 surpassing the estimated -$9.80 by +6.12%.
Earnings released on 7 Aug 2023
EPS came in at -$10.40 surpassing the estimated -$13.00 by +20.00%.
Earnings released on 11 May 2023
EPS came in at -$13.60 surpassing the estimated -$13.80 by +1.45%.
Earnings released on 28 Mar 2023
EPS came in at -$13.00 falling short of the estimated -$12.60 by -3.17%.
Earnings released on 10 Nov 2022
EPS came in at -$16.00 matching the estimated -$16.00.
Earnings released on 11 Aug 2022
EPS came in at -$17.60 surpassing the estimated -$18.40 by +4.35%.
Earnings released on 12 May 2022
EPS came in at -$0.79 falling short of the estimated -$0.76 by -3.95%.
Earnings released on 29 Mar 2022
EPS came in at -$0.31 surpassing the estimated -$0.93 by +66.67%.
Earnings released on 12 Nov 2021
EPS came in at -$1.39 falling short of the estimated -$0.85 by -63.53%.
Earnings released on 12 Aug 2021
EPS came in at -$0.12 surpassing the estimated -$0.37 by +67.57%.
Earnings released on 17 May 2021
EPS came in at -$0.46 falling short of the estimated -$0.32 by -43.75%, while revenue for the quarter reached $127.00K .
Earnings released on 22 Mar 2021
EPS came in at -$1.98 , while revenue for the quarter reached -$1.40M .
Earnings released on 7 Dec 2020
EPS came in at -$0.06 .
Earnings released on 8 Oct 2020
EPS came in at -$0.01 .
VINC Stock Performance
Access detailed VINC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.